Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs.
- DOI
- 10.3390/biomedicines9121846
- Published
- 2021-12-06
- Container
- Biomedicines
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/biomedicines9121846,
title = {Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs.},
author = {Vagapova E and Kozlov M and Lebedev T and Ivanenko K and Leonova O and Popenko V and Spirin P and Kochetkov S and Prassolov V.},
year = {2021},
journal = {Biomedicines},
doi = {10.3390/biomedicines9121846},
url = {https://doi.org/10.3390/biomedicines9121846}
}RIS
TY - JOUR TI - Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs. AU - Vagapova E AU - Kozlov M AU - Lebedev T AU - Ivanenko K AU - Leonova O AU - Popenko V AU - Spirin P AU - Kochetkov S AU - Prassolov V. PY - 2021 JO - Biomedicines DO - 10.3390/biomedicines9121846 UR - https://doi.org/10.3390/biomedicines9121846 ER -
APA
E, V., M, K., T, L., K, I., O, L., V, P., P, S., S, K., & V., P. (2021). Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs.. Biomedicines. https://doi.org/10.3390/biomedicines9121846
Source records
- europe-pmc · retrieved 2026-09-26T21:06:08.288Z